Claims
- 1. A method of evolving a cell to acquire a desired function, comprising:
(i.) introducing a library of DNA fragments into a plurality of cells, whereby at least one of the fragments undergoes recombination with a segment in tile genome or an episome of the cells to produce modified cells and, optionally, recombining a plurality of nucleic acids from the modified cells to produce additionally modified cells, (ii.) screening the modified cells or the additionally modified cells for modified cells that have evolved toward acquisition of the desired function, (iii.) recombining DNA from the modified cells that have evolved toward the desired function with a further library of DNA fragments, at least one of which undergoes recombination with a segment in the genome or the episome of the modified cells to produce further modified cells, or recombining DNA between the modified cells that have evolved toward the desired function to produce further modified cells, (iv) screening the further modified cells for further modified cells that have further evolved toward acquisition of the desired function, repeating (iii) and (iv.) as required until the further modified cells have acquired the desired function
- 2. The method of claim 1, comprising recombining a plurality of nucleic acids from the modified cells to produce additionally modified cells, which additionally modified cells comprise more diverse DNA than the modified cells, wherein the additionally modified cells are screened to identify cells that have evoloved towards acquisition of the desired function.
- 3. The method of claim 1, wherein the library is a library of locked in prophage.
- 4. The method of claim 1, wherein the step of recombining DNA between the modified cells is performed by protoplast fusing the modified cells and allowing fused cells to recombine.
- 5. The method of claim 4, wherein DNA from the modified cells is reiteratively recombined by protoplast fusion prior to selection or screening.
- 6. The method of claim 1, wherein the step of recombining DNA between the modified cells is performed by protoplast fusing the modified cells and allowing fused cells to recombine, the method further comprising enriching the resulting fused cell population for fused cells comprising more than two cell genomes
- 7. The method of claim 6, further comprising reiteratively recombining the modified cells by protoplast fusion, allowing the resulting protoplasts to form into spores and then into mycelia, and fusing the resulting mycelia into protoplasts, wherein said reiterative recombining is performed before or after enriching tile resulting fused cell population for fused cells comprising more than two cell genomes.
- 8. The method of claim 1, wherein the library of DNA fragments is a substantially complete genomic library from at least one heterologous cell type
- 9. The method of claim 1, wherein the library of fragments comprises natural variants of a gene from different individuals
- 10. The method of claim 1, further comprising subdividing the modified cells into first and second pools, isolating the further library of DNA fragments from the second pool and introducing the further library of DNA fragments into the first pool
- 11. The method of claim 1, wherein the library of DNA fragments are components of viruses and the introducing occurs by infection of the cells with the viruses.
- 12. The method of claim 1, wherein the library of DNA fragments is cloned into a suicide vector incapable of permanent episomal existence in the cells
- 13. The method of claim 12. wherein the suicide vector further comprises a selective marker.
- 14. The method of claim 1, further comprising coating the library or further library of DNA fragments with recA protein to stimulate recombination with the segment of the genome.
- 15. The method of claim 1, further comprising denaturing the library of fragments to produce single-stranded DNA, reannealling the single-stranded DNA to produce duplexes some of which contain mismatches at points of variation in the fragments, and selecting duplexes containing mismatches by affinity chromatography to immobilized MutS
- 16. The method of claim 1, further comprising fragmenting the library of fragments to produce subfragments before denaturation, and reassembling duplexes of subfragments containing mismatches into reassembled fragments.
- 17. The method of claim 16, wherein the average diversity between reassembled fragments is at least five times greater than the average diversity between fragments
- 18. The method of claim 17, wherein the desired function is secretion of a protein, and the plurality of cells further comprises a construct encoding the protein
- 19. The method of claim 18, wherein the protein is inactive unless secreted, and the modified or further modified cells having evolved toward acquisition of the desired function are screened by propagating the cells and recovering surviving cells.
- 20. The method of claim 19, wherein the protein is β-lactamase or alkaline phosphatase, and the modified or further modified cells having evolved toward acquisition of the desired function are screened by monitoring metabolism of a chromogenic substrate of the alkaline phosphatase, or by monitoring resistance to a β-lactamase antibiotic.
- 21. The method of claim 18, wherein the protein is an antibody and the plurality of cells is E. coli.
- 22. The method of claim 21, wherein the construct further encodes a marker which is expressed with the protein as a fusion protein, and the screening comprises propagating the modified or further modified cells and identifying cells secreting the fusion protein by FACS sorting.
- 23. The method of claim 22, wherein the marker protein is linked to a phospholipid anchoring domain that anchors the marker protein to the cell surface after secretion from the cell.
- 24. The method of claim 22, wherein the cells are contained in agar drops which confine secreted protein in proximity with the cell secreting the protein.
- 25. The method of claim 18, wherein at least one fragment in the library encodes a signal sequence and the at least one fragment is incorporated into a construct operably linked to a sequence encoding a protein to be secreted from the cells
- 26. The method of claim 15, wherein at least one fragment in the library encodes a signal processing enzyme and the cells contain a construct encoding a protein to be secreted operably linked to a signal sequence
- 27. The method of claim 15, wherein at least one fragment in the library encodes a gene selected from the group consisting of SecA, SecB, SecE, SecD and SecF genes.
- 28. The method of claim 1, wherein the desired function is enhanced recombination
- 29. The method of claim 1, wherein the library of fragments comprises a cluster of genes collectively conferring recombination capacity
- 30. The method of claim 1, wherein the at least one gene is selected from the group consisting of recA, recBCD, recBC, recE, recF, recG, recO, recQ, recR, recT, ruvA, ruvB, ruvC, sbcB, ssb, topA, gyrA and B, lig, polA, uvrD, E, recL, mutU, and helD.
- 31. The method of claim 30, wherein the plurality of cells further comprises a gene encoding a marker whose expression is prevented by a mutation removable by recombination, and the modified or further modified cells are screened by their expression of the marker resulting from removal of the mutation by recombination.
- 32. The method of claim 30, wherein in the screening steps, the modified or further modified cells are exposed to a mutagen and modified or further modified cells having evolved toward acquisition of the desired function are selected by their survival of the exposure, survival being conferred by the cells' enhanced recombinational capacity to remove damage induced by the mutagen.
- 33. The method of claim 30, wherein the mutagen is radiation.
- 34. The method of claim 33, wherein enhanced recombination is conferred by increased genomic copy number of the modified or further modified cells
- 35. The method of claim 25, wherein at least one gene is selected from a replication or cell septation gene
- 36. The method of claim 35. wherein the modified or further modified cells having evolved toward acquisition of the desired function are selected by their capacity for syncytium formation or cell fusion
- 37. The method of claim 1, wherein the plurality of cells are plant cells and the desired property is improved resistance to a chemical or microbe, and in the screening the steps, the modified or further modified cells are exposed to the chemical or microbe and modified or further modified cells having evolved toward the acquisition of the desired function are selected by their capacity to survive the exposure
- 38. The method of claim 1, wherein the plurality of cells are microspores.
- 39. The method of claim 1, wherein the further modified cells are microspores.
- 40. The method of claim 1, wherein the further modified cells are microspores, and wherein the microspores are used to pollenate a population of plants.
- 41. The method of claim 37, wherein the microorganism is a virus, bacterium, or fungus.
- 42. The method of claim 37, wherein the chemical is a viricide, fungicide, insecticide, bactericide or herbicide
- 43. The method of claim 42, wherein the chemical is BT-toxin.
- 44. The method of claim 42, wherein the chemical is glyphosate or atrazine.
- 45. The method of claim 42, further comprising propagating a plant cell having acquired the desired function to produce a transgenic plant
- 46. The method of claim 42, wherein the plurality of cells are embryonic cells of an animal, and the method further comprises propagating the transformed cells to transgenic animals
- 47. The method of claim 46 wherein the modified cells are screened as components of the transgenic animals
- 48. The method of claim 46, further comprising obtaining embryonic cells from the transgenic animals having modified cells evolved toward acquisition of the property and transforming the cells with the further library.
- 49. The method of claim 46, further comprising isolating DNA from transgenic animals that have evolved toward acquisition of the property and introducing the DNA into fresh embryonic cells
- 50. The method of claim 46, wherein the animal is a fish
- 51. The method of claim 46, wherein at least one of the fragments encodes a growth hormone and the desired property is increased size of the animal
- 52. A method of enhancing tissue-specific expression of a protein in a transgenic animal, comprising
(i.) recombining at least first and second forms of a gene encoding a protein, the forms differing from each other in at least two nucleotides, to produce a library of chimeric genes, (ii) screening the library to identify at least one chimeric gene, which as a component of a transgene, confers enhanced expression of the protein in cells from the tissue relative to a transgene containing the wildtype form of the gene, (iii.) recombining the at least one chimeric gene with a further form of the gene, the same or different from the first and second forms, to produce a further library of chimeric genes, (iv.) screening the further library for at least one further chimeric gene that as a component of a transgene confers enhanced expression of the protein in cells from the tissue relative to a transgene comprising the chimeric gene in the previous screening step, (v) repeating (iii) and (iv), as necessary until the further chimeric gene confers a desired level of expression in cells from the tissue
- 53. The method of claim 52, wherein the at least two forms of a gene differ from each other within a coding sequence
- 54. The method of claim 52, wherein the at least two forms of a gene differ from each other within a regulatory sequence
- 55. The method of claim 52 wherein the cells are mammary gland cells
- 56. The method of claim 52, wherein the transgene comprises a milk-protein enhancer, a milk-protein promoter, a signal sequence and a protein coding sequence in operable linkage.
- 57. The method of claim 52, whereby the protein and marker are expressed as a fusion protein.
- 58. The method of claim 57, whereby enhanced expression is determined by detecting the presence of the marker as a component of the fusion protein outside the cell expressing the fusion protein.
- 59. A method of performing in vivo recombination, the method comprising:
providing a cell incapable of expressing a cell septation gene, introducing at least first and second segments from at least one gene into a cell, the segments differing from each other in at least two nucleotides, whereby the segments recombine to produce a library of chimeric genes; and, selecting a chimeric gene from the library having an acquired function.
- 60. The method of claim 59, wherein the cell contains a construct expressing antisense mRNA of the cell septation gene preventing expression of the septation gene.
- 61. The method of claim 59, wherein the cell is exposed to a drug rendering it incapable of expressing the cell septation gene
- 62. The method of claim 59, wherein the cell septation gene contains a mutation preventing its expression.
- 63. A method of predicting efficacy of a drug in treating a viral infection, the method comprising
(i) recombining a nucleic acid segment from a virus, whose infection is inhibited by a drug, with at least a second nucleic acid segment from the virus, the second nucleic acid segment differing from the nucleic acid segment in at least two nucleotides, to produce a library of recombinant nucleic acid segments. (ii) contacting host cells with a collection of viruses having genomes including the recombinant nucleic acid segments in a media containing the drug, and collecting progeny viruses resulting from infection of the host cells, (iii.) recombining a recombinant DNA segment from a first progeny virus with at least a recombinant DNA segment from a second progeny virus to produce a further library of recombinant nucleic acid segments, (iv.) contacting host cells with a collection of viruses having genomes including the further library or recombinant nucleic acid segments, in media containing the drug, and collecting further progeny viruses produced by the host cells, and, (v) repeating (iii) and (iv), as necessary, until a further progeny virus has acquired a desired degree of resistance to the drug, whereby the degree of resistance acquired and the number of repetitions of (iii.) and (iv) needed to acquire it provide a measure of the efficacy of the drug in treating the virus
- 64. The method of claim 63, wherein the media contains a combination of drugs
- 65. The method of claim 63, wherein the virus is HIV.
- 66. A method of predicting efficacy of a drug in treating an infection by a pathogenic microorganism, the method comprising.
(i.) transforming a plurality of cells of the microorganism with a library of DNA fragments at least some of which undergo recombination with segments in the genome of the cells to produce modified microorganism cells, (ii) propagating modified microorganisms in a media containing the drug, and recovering surviving microorganisms, (iii) recombining DNA from surviving microorganisms with a further library of DNA fragments at least some of which undergo recombination with cognate segments in the DNA from the surviving microorganisms to produce further modified microorganisms cells, (iv) propagating further modified microorganisms, in media containing the drug and collecting further surviving microorganisms, (v) repeating (iii) and (iv), as necessary, until a further surviving microorganism has acquired a desired degree of resistance to the drug, whereby the degree of resistance acquired and the number of repetitions of (iii) arid (iv) needed to acquire it provide a measure of the efficacy of the drug in killing the pathogenic microorganism
- 67. The method of claim 66. further comprising repeatedly recombining DNA from the modified microorganisms to produce the modified microorganism cells, wherein the repeated recombination is performed prior to propagating the modified microorganism cells in a media containing the drug
- 68. The method of claim 66, further. comprising dividing surviving microorganisms into first and second pools, isolating the further library of DNA from the first pool and transforming the second pool with the further library
- 69. The method of claim 66, wherein the further library of DNA is obtained from a different microorganism
- 70. A method of evolving a cell to acquire a desired function, the method comprising:
(a) providing a population of different cells, (b) culturing the cells under conditions whereby DNA is exchanged between cells, forming cells with hybrid genomes, (c) screening or selecting the cells for cells that have evolved toward acquisition of a desired property, and, (d) repeating steps (b) and (c) with the selected or screened cells forming the population of different cells until a cell has acquired the desired property.
- 71. The method of claim 70, further comprising reiteratively exchanging DNA between the cells with hybrid genomes prior to step (c)
- 72. The method of claim 70, wherein DNA is exchanged between the cells by conjugation
- 73. The method of claim 70, wherein DNA is exchanged between the cells by phage-mediated transduction
- 74. The method of claim 70, wherein DNA is exchanged between the cells by fusion of protoplasts of the cells
- 75. The method of claim 74, wherein the cells are microspores
- 76. The method of claim 70, wherein DNA is exchanged between the cells by fusion of protoplasts of more than two cells
- 77. The method of claim 76, wherein the cells are microspores
- 78. The method of claim 70, wherein DNA is exchanged between the cells by fusion of protoplasts of more than two cells, the method additionally comprising selecting protoplasts of more than two cells prior to regeneration of single-genome cells and selection for acquisition of the desired property.
- 79. The method of claim 70, wherein DNA is exchanged between the cells by sexual recombination of the cells
- 80. The method of claim 70, further comprising transforming a DNA library into the cells
- 81. The method of claim 70, wherein the recipient cells are recD-.
- 82. The method of claim 70, wherein the recipient cells are treated with a recD inhibitor.
- 83. The method of claim 70, wherein the recipient cells are bacillus.
- 84. A method of evolving a cell to acquire a desired property, comprising:
(i.) forming protoplasts of a population of different cells, (ii.) fusing the protoplasts to form hybrid protoplasts, in which genomes from the protoplasts recombine to form hybrid genomes; (iii.) incubating the hybrid protoplasts under conditions promoting regeneration of cells, thereby producing regenerated cells. (iv) optionally repeatedly forming protoplasts from the regenerated cells, fusing the protoplasts to form hybrid protoplasts, in which genomes from the protoplasts recombine to form additional hybrid genomes, incubating the additional hybrid protoplasts under conditions promoting regeneration of cells, thereby producing additional regenerated cells, (v) selecting or screening to isolate regenerated cells or additionally regenerated cells that have evolved toward acquisition of the desired property, and, (vi) repeating steps (i)-(v) with regenerated cells in step (iii) or additional regenerated cells in step (iv) being used to form the protoplasts in step (i) until the regenerated cells have acquired the desired property
- 85. The method of claim 84, comprising step (iv), wherein step (iv) is performed prior to step (v)
- 86. The method of claim 84, wherein the hybrid protoplasts comprise cells having more than two parental genomes
- 87. The method of claim 84, wherein the different cells are fungal cells, and the regenerated cells are fungi mycelia.
- 88. The method of claim 87, wherein protoplasts are provided by treating mycelia or spores with an enzyme
- 89. The method of claim 87, wherein the fungal cells are from a fragile strain, lacking capacity for intact cell wall synthesis, whereby protoplast form spontaneously.
- 90. The method of claim 87, further comprising treating the mycelia with an inhibitor of cell wall formation to generate protoplasts.
- 91. The method of claim 84, further comprising selecting or screening to isolate regenerated cells with hybrid genomes free from cells with parental genomes.
- 92. The method of claim 84, wherein a first subpopulation of cells contain a first marker and the second subpopulation of cells contain a second marker, and the method further comprising selecting or screening to identify regenerated cells expressing both the first and second marker
- 93. The method of claim 84, wherein the first marker is a membrane marker and the second marker is a genetic marker
- 94. The method of claim 84, wherein the first marker is a first subunit of a heteromeric enzyme and the second marker is a second subunit of the heteromeric enzyme
- 95. The method of claim 84, further comprising transforming protoplasts with a library of DNA fragments in at least one cycle
- 96. The method of claim 95, wherein the DNA fragments are accompanied by a restriction enzyme.
- 97. The method of claim 84, further comprising exposing the protoplasts to ultraviolet irradiation in at least one cycle
- 98. The method of claim 84, wherein the desired property is the expression of a protein, primary metabolite, or secondary metabolite
- 99. The method of claim 84, wherein the desired property is the secretion of a protein or secondary metabolite
- 100. The method of claim 99, wherein the secondary metabolite is selected from taxol, cyclosporin A, and erythromycin
- 101. The method of claim 84, wherein the desired property is capacity for meiosis
- 102. The method of claim 84, wherein the desired property is compatibility to form a heterokaryon with another strain
- 103. The method of claim 84, further comprising exposing the protoplasts or mycelia to a mutagenic agent in at least one cycle
- 104. A method of evolving a cell to acquire a desired property, comprising
(i.) forming protoplasts of a population of different cells (ii.) fusing the protoplasts to form hybrid protoplasts, in which genomes from the protoplasts recombine to form hybrid genomes, (iii) incubating the hybrid protoplasts tinder conditions promoting regeneration of cells, thereby producing regenerated cells, (iv) repeatedly forming protoplasts from the regenerated cells, fusing the protoplasts to form hybrid protoplasts. in which genomes from the protoplasts recombine to form additional hybrid genomes, incubating the additional hybrid protoplasts under conditions promoting regeneration of cells, thereby producing additional regenerated cells, and, (v) selecting or screening to isolate regenerated cells or additionally regenerated cells that have evolved toward acquisition of the desired property
- 105. The method of claim 104, further comprising repeating steps (i)-(v) with regenerated cells in step (iii) or additional regenerated cells in step (iv.) being used to form the protoplasts in step (i.) until the regenerated cells have acquired the desired property.
- 106. The method of claim 104. comprising step (iv), wherein step (iv) is performed prior to step (v)
- 107. The method of claim 104, wherein the hybrid protoplasts comprise cells having more than two parental genomes
- 108. The method of claim 104, wherein the different cells are fungal cells, and the regenerated cells are fungi mycelia
- 109. The method of claim 108, wherein protoplasts are provided by treating the mycelia or fungal spores with an enzyme
- 110. The method of claim 108, wherein the fungal cells are from a fragile strain, lacking capacity for intact cell wall synthesis, whereby protoplast form spontaneously.
- 111. The method of claim 108, further comprising treating the mycelia with an inhibitor of cell wall formation to generate protoplasts.
- 112. The method of claim 104, further comprising selecting or screening to isolate regenerated cells with hybrid genomes free from cells with parental genomes.
- 113. The method of claim 104, wherein a first subpopulation of cells contain a first marker and the second subpopulation of cells contain a second marker, and the method further comprising selecting or screening to identify regenerated cells expressing both the first and second marker
- 114. The method of claim 104, wherein the first marker is a membrane marker and the second marker is a genetic marker
- 115. The method of claim 104, wherein the first marker is a first subunit of a heteromeric enzyme and the second marker is a second subunit of the heteromeric enzyme.
- 116. The method of claim 104, further comprising transforming protoplasts with a library of DNA fragments in at least one cycle
- 117. The method of claim 116, wherein the DNA fragments are accompanied by a restriction enzyme
- 118. The method of claim 104, further comprising exposing the protoplasts to ultraviolet irradiation in at least one cycle
- 119. The method of claim 104, wherein the desired property is the expression of a protein, primary metabolite, or secondary metabolite
- 120. The method of claim 104, wherein the desired property is the secretion of a protein or secondary metabolite
- 121. The method of claim 120, wherein the secondary metabolite is selected from taxol, cyclosporin A, and erythromycin.
- 122. The method of claim 104, wherein the desired property is capacity for meiosis.
- 123. The method of claim 104, wherein the desired property is compatibility to form a heterokaryon with another strain
- 124. The method of claim 104. further comprising exposing the protoplasts or mycelia to a mutagenic agent in at least one cycle.
- 125. A method of evolving a cell toward acquisition of a desired property comprising
(a) providing a population of different cells, (b) isolating DNA from a first subpopulation of the different cells and encapsulating the DNA in liposomes, (c) forming protoplasts from a second subpopulation of the different cells, (d) fusing the liposomes with the protoplasts whereby DNA from the liposomes is taken Lip by the protoplasts and recombines with the genomes of the protoplasts, (e) incubating the protoplasts under regenerating conditions, (f) selecting or screening for regenerating or regenerated cells that have evolved toward the desired property, and, (g) repeating steps (a)-(t) with the cells that have evolved toward the desired property forming the population of different cells in step (a)
- 126. A method of evolving a cell toward acquisition of a desired property, the method comprising.
(a) introducing a DNA fragment library cloned into an artificial chromosome into a population of cells; (b) culturing the cells under conditions whereby sexual recombination occurs between the cells, whereby DNA fragments cloned into the artificial chromosome homologously recombine with corresponding segments of endogenous chromosomes of the populations of cells, and endogenous chromosomes recombine with each other, and (c) screening or selecting for cells that have evolved toward acquisition of the desired property.
- 127. The method of claim 126, wherein the cells are yeast cells and the artificial chromosome is a YAC.
- 128. The method claim 126, further comprising
(d) culturing the cells surviving the screening or selecting step under conditions whereby sexual recombination occurs between cells, whereby further recombination occurs between endogenous chromosomes; (e) screening or selecting for further cells that have evolved toward acquisition of the desired property; (f) repeating steps (d) and (e) as needed until the desired property has been acquired
- 129. A method of evolving a DNA segment for acquisition of a desired properly the method comprising
(a) providing a library of variants of the segment, each variant cloned into separate copies of an artificial chromosome, (b) introducing the copies of the artificial chromosome into a population of cells, (c) culturing the cells under conditions whereby sexual recombination occurs between cells and homologous recombination occurs between copies of the artificial chromosome bearing the variants, and, (d) screening or selecting for variants that have evolved toward acquisition of the desired property
- 130. A RecA protein selected from the group consisting of clone 2, clone 4, clone 5, clone 6, clone 13, and conservative variations thereof.
- 131. A RecA protein according to claim 130, wherein the protein is hyper-recombinogenic
- 132. A method of evolving a recA protein to increase recombinogenic activity, the method comprising
shuffling a population of nucleic acid segments encoding variants of recA including a nucleic acid segment selected from the group consisting of clone 2, clone 4, clone 5, clone 6 and clone 13, to produce recombinant segments; screening or selecting a recombinant segment with increased recombinogenic activity relative to the nucleic acid segment selected from the group.
- 133. A method of poolwise recombination and selection of cells, the method comprising:
(i) introducing a library of DNA fragments into a plurality of recipient cells, whereby a plurality of fragments of the library undergo recombination with a genome or an episome of a plurality of recipient cells to produce a plurality of modified cells, whereby the plurality of modified cells comprise a plurality of different modified fragments; (ii) fusing at least two of the modified cells, whereby genomes of the at least two modified cells recombine, (iii) segregating the resulting fused cell to produce a plurality of regenerated cells, each with a single genome, and, (iv) selecting the regenerated cells for a desired properly
- 134. The method of claim 133, wherein the fragments undergo homologous recombination with the genome or episome
- 135. The method of claim 133, wherein the fragments undergo non-homologous recombination with the genome or episome
- 136. The method of claim 133, wherein the library is a library of locked in prophage
- 137. The method of claim 133, wherein tile at least two cells are fused by protoplast fusion.
- 138. The method of claim 133, wherein more than two of the modified cells are fused to form a cell with more than two genomes
- 139. The method of claim 133, further comprising selecting the modified cells for the desired property prior to fusing at least two of the modified cells
- 140. The method of claim 133, wherein more than two of the modified cells are fused to form a plurality of cells with more than two genomes, the method further comprising selecting the plurality of cells with more than two genomes for the presence of more than two genomes.
- 141. The method of claim 133, wherein the property selected for is selected from increased production of a desired protein, increased production of a primary metabolite, increased production of a secondary metabolite, increased tolerance to acidic conditions, increased tolerance to basic conditions, increased tolerance to organic solvents, increased tolerance to high salt conditions, increased tolerance to high or low temperatures and an increased ability to convert a first molecule into a second molecule
- 142. The method of claim 133, wherein the property selected for is improved when a protein contributing to the property is expressed at an elevated level as compared to wild-type
- 143. The method of claim 133, wherein tile property selected for is selected from increased ethanol production, increased amino acid production, increased vitamin production, increased enzymatic activity, removal of unwanted co-metabolites, improved utilization of carbon or nitrogen sources, and adaptation to fermenter conditions
- 144. The method of claim 133, wherein the modified cells are selected from bacteria, archaebacteia, and eukaryotic cells
- 145. The method of claim 133, wherein the modified cells are selected from plant cells, animal cells and bacteria
- 146. A method of increasing resistance to virus infection in cells comprising
introducing a shuffled library comprising at least one shuffled interferon gene into animal cells, thereby creating an initial library of animal cells or animals, challenging the initial library with the virus, selecting animal cells or animals from the initial library which are resistant to the virus, recovering a plurality of transgenes from a plurality of animal cells or animals which are resistant to the virus; shuffling the plurality of transgenes to produce an evolved library of animal cells or animals challenging the evolved library of animal cells or animals with the virus; and, selecting cells or animals from the evolved library the which are resistant to the virus
- 147. The method of claim 146, wherein the animal cells are fish eggs.
- 148. The method of claim 146, wherein the interferon gene is an alpha interferon gene from a fish.
- 149. A method of whole genome shuffling in plants, comprising:
isolating genomic DNA from a source plant and fragmenting the genomic DNA; cloning the resulting fragmented genomic DNA into a cloning vector to produce a primary genomic library; transducing the primary genomic library into target plant cells, selecting the resulting transduced target plant cells, or a plant comprising transduced target plant cells for acquisition of a desired trait or property, isolating genomic DNA from a plurality of target cells which display the desired property, cloning the isolated genomic DNA from the plurality of target cells into a cloning vector to produce a secondary genomic library, transducing the secondary genomic library into the target plant cells; and, selecting the resulting transduced target plant cells, or a plant comprising transduced target plant cells for acquisition of a desired trait or property, thereby providing an improved plant with a new phenotype
- 150. The method of claim 149, wherein the cloning vector comprises A tumefaciens left and right borders
- 151. The method of claim 149, wherein the cloning vector is pGA482.
- 152. The method of claim 149, wherein the primary library is introduced into the plant by a method selected from electroporation, protoplast fusion, and particle bombardment.
- 153. The method of claim 149, wherein the desired trait or property is selected from salt tolerance, pest resistance and temperature tolerance.
- 154. The method of claim 149, further comprising cloning a target DNA from the improved plant, which target DNA comprises a sequence which contributed to the new phenotype.
- 155. A method of selecting for increased copy number of a nucleic acid sequence contributing to a desired phenotype of a target cell comprising:
providing a genomic library in a suicide vector comprising a dose-sensitive selectable market, transducing the genomic library into a population of target cells; selecting the population of target cells for increasing doses of the selectable marker under conditions in which the suicide vector does not replicate episomally, selecting a plurality of target cells for the desired phenotype; recombining the selected plurality of target cells, and, selecting the selected plurality of target cells for the desired phenotype
- 156. The method of claim 155, wherein the dose-sensitive selectable marker is kanamycin
- 157. The method of claim 155, wherein the plurality of selected target cells are recombined using a technique selected from split pool transduction, and protoplast fusion
- 158. The method of claim 155, further comprising repeating the steps of
selecting a plurality of target cells for the desired phenotype, recombining the selected plurality of target cells, and, selecting the selected plurality of target cells for the desired phenotype
- 159. The method of claim 155, further comprising successively selecting the plurality of target cells with an increasing dose of a selection agent corresponding to the selectable marker.
- 160. A method of producing a library of diverse multicellular organsims, the method comprising:
providing a pool of male gametes and a pool of female gametes, wherein at least one of the male pool or the female pool comprises a plurality of different gametes derived from different strains of a species or different species, wherein the male gametes fertilize the female gametes, permitting at least a portion of the resulting fertilized gametes to grow into reproductively viable organisms, repeatedly crossing the reproductively viable organisms to produce a library of diverse organisms, and, selecting the library for a desired trait or property.
- 161. The method of claim 160, wherein the library of diverse organisms comprise a plurality of plants
- 162. The method of claim 161, wherein the plants are selected from: Gramineae, Fetucoideae, Poacordeae, Agrostis, Phleum, Dactylis, Sorgum, Setaria, Zea, Oryza, Triticum, Secale, Avena, Hordeum, Saccharum, Poa, Festuca, Stenotaphrum, Cynodon, Coix, Olyreae, Phareae, Compositae, and Lefuminosae
- 163. The method of claim 161, wherein the plants are selected from corn), rice, wheat, rye, oats, barley, pea, beans, lentil, peanut, yam bean, cowpeats, velvet beans, soybean, clover, alfalfa, lupine, vetch, lotus, sweet clover, wisteria, sweetpea, sorghum, millet, sunflower, and canola
- 164. The method of claim 160, wherein the library of diverse organisms comprise a plurality of animals
- 165. The method of claim 164, wherein the animals are selected from non-human mammals and fish
- 166. A library produced by the method of claim 160
- 167. The method of claim 160, further comprising
crossing a plurality of selected library members by pooling gametes from the selected members and repeatedly crossing any resulting additional reproductively viable organisms to produce a second library of diverse organisms, and, selecting the second library for a desired trait or property
- 168. The second library made by the method of claim 167
- 169. A method for whole genome shuffling through organized heteroduplex shuffling, the method comprising
(a). providing chromosomal DNA of an organism which is targeted for shuffling, digesting the chromosomal DNA with one or more restriction enzymes, ligating the chromosomal DNA into a cosmid, the cosmid comprising at least two rare restriction enzyme recognition sites, aliquoting, purifying, and storing sufficient cosmids to represent a complete chromosome, (b) mutagenizing aliquots of the library in vitro using a mutagen, (c). transfecting a sample from a plurality of the mutagenized aliquots into a population of target cells, (d) assaying resulting transfectants for phenotypic improvements; (e) growing transfected cells harboring a mutant library of the identified cosmid(s) on media and screening the resulting cell colonies for independent mutants conferring an desired phenotype; (f) isolating and pooling DNA from cells identified in the screening, (g). dividing the selected pools and digesting at least one sample with a rare-cutting restriction enzyme, pooling the cleaved samples, denaturing the samples, reannealing the samples and religating the samples, and, (h). transfecting target cells with the resulting heteroduplexes and propagating the cells to allow recombination to occur between the strands of the heteroduplexes in vivo
- 170. The method of claim 169, further comprising additionally screening the transfectants
- 171. The method of claim 169, further comprising further shuffling the heteroduplexes by recursive in vitro heteroduplex formation and in vivo recombination prior to additionally screening the transfectants
- 172. The method of claim 169, further comprising performing an additional mutagenesis step to increase diversity during the shuffling process
- 173. The method of claim 169, further comprising combining one or more heteroduplexes into a host chromosome by chromosome integration.
- 174. The method of claim 173, further comprising repeating steps (a).-(h), using the organism resulting from chromosome integration as the source for chromosomal DNA in step (a).
- 175. The method of claim 169, wherein the cosmid comprises restriction sites for Sfr or NotI.
- 176. The method of claim 169, wherein the transfectants are assayed as a pool from each mutagenized aliquot
- 177. The method of claim 169, wherein a positive assay result indicates that a cosmid from a particular aliquot can confer phenotypic improvements and contains large genomic fragments that are suitable targets for heteroduplex mediated shuffling.
- 178. The method of claim 169, wherein the mutagen is a chemical mutagen
- 179. The method of claim 169, wherein growing transfected cells harboring a mutant library of the identified cosmid(s) on media comprises plating the transfected cells on solid media
CROSS-REFERENCE SO RELATED APPLICATION
[0001] This application is a continuation-in part of U.S. Ser. No. 09/116,188, filed Jul. 15, 1998, which claims priority to U.S. S. No. 60/035,054, filed Jan. 17, 1997, and PCT/US/98/00852, filed Jan. 16, 1998 (attorney Docket 018097-020710PC), (designating the U S.). The subject application claims priority to each of these prior applications, each of which is also incorporated by reference in its entirety for all purposes.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60035054 |
Jan 1997 |
US |
Continuations (2)
|
Number |
Date |
Country |
Parent |
09718262 |
Nov 2000 |
US |
Child |
10194686 |
Jul 2002 |
US |
Parent |
09354922 |
Jul 1999 |
US |
Child |
10194686 |
Jul 2002 |
US |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
09116188 |
Jul 1998 |
US |
Child |
10194686 |
Jul 2002 |
US |
Parent |
PCT/US98/00852 |
Jan 1998 |
US |
Child |
10194686 |
Jul 2002 |
US |